Kalvista Pharmaceuticals Inc (KALV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 04-2016 | 03-2016 | 01-2016 | 12-2015 | 09-2015 | |
| Sales | 0 | 7 | 348 | 8 | 7 |
| Gross Profit | N/A | 7 | 348 | 8 | 7 |
| Operating Expenses | 0 | 6,535 | 4,163 | 5,577 | 4,906 |
| Operating Income | N/A | -6,528 | -3,815 | -5,569 | -4,899 |
| Interest Expense | 0 | 88 | 0 | 88 | 95 |
| Other Income | 0 | 9 | 1,863 | -2 | 3 |
| Pre-tax Income | 0 | -6,607 | -1,952 | -5,659 | -4,991 |
| Net Income Continuous | N/A | -6,607 | -1,952 | -5,659 | -4,991 |
| Net Income | $N/A | $-6,607 | $-1,952 | $-5,659 | $-4,991 |
| EPS Basic Total Ops | N/A | -3.50 | -4.85 | 93.42 | -2.66 |
| EPS Basic Continuous Ops | N/A | -3.51 | -3.09 | 93.43 | -2.66 |
| EPS Diluted Total Ops | N/A | -3.50 | -4.85 | 93.42 | -2.66 |
| EPS Diluted Continuous Ops | N/A | -3.51 | -3.09 | 93.43 | -2.66 |
| EBITDA(a) | $N/A | $-6,502 | $-3,789 | $-6,402 | $-4,851 |